Radical Numerics CEO calls the handling of its AI-designed phage announcement a mistake after its partner disagreed over disclosure

Radical Numerics · Company post

Read the source (opens in a new tab)
What happened
Eric Nguyen, co-founder and CEO of Radical Numerics, posted a note on November 9, 2026 about the company's phage work with Tabula Bioscience, responding to public discussion involving Tabula and George Church.
Key points
  • He says the two companies "had different perspectives on when and how to share this milestone, including public concerns around AI, biosecurity, and the number of clinical cases."
  • Radical "believed the broader implications of this new capability in genome design warranted earlier disclosure rather than later," he writes, and understood Tabula no longer wanted to co-announce.
  • He says Radical should have communicated more directly and ensured all partners' contributions were represented: "This was a mistake." It is setting clearer expectations on attribution and communication.
  • He says Tabula "played a leading role in the broader effort"; Radical's part was phages designed with its genome language models, included in a cocktail given to a patient under compassionate use.
Evidence
The CEO's own post on the company blog. It does not say which company raised the biosecurity concerns or what they were, and gives no clinical outcome or new data.
Uncertain
The note gives only Radical's side; Tabula Bioscience's account was not reviewed for this entry.

See it in the latest record